INOVIO to Participate in Upcoming Investor Conferences
INOVIO (NASDAQ: INO) announced participation in two investor events in New York.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
INOVIO (NASDAQ: INO) announced participation in two investor events in New York. The company will join the Cantor Global Healthcare Conference on Wednesday, September 9, featuring a fireside chat at 3:20 PM ET with a live webcast. INOVIO will also present at the H.C. Wainwright 28th Annual Global Investment Conference, with a virtual presentation available starting Friday, September 11 at 7:00 AM ET. Webcast and virtual links will host replays for 90 days, and management plans to hold one-on-one meetings with investors during both conferences.
Details
News Market Reaction – INO
On Sep 2, the first trading day after this news, INO closed 2.26% above the previous close. Argus tracked a peak move of +2.5% during that session. Argus tracked a trough of -4.3% from its starting point during tracking. Our momentum scanner recorded 11 alerts for this stock that day. Relative volume reached 2.5x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 2 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Cantor Global Healthcare Conference (
Date: Wednesday, September 9
Fireside Chat: 3:20 PM ET
Webcast: https://sqps.onstreamsecure.com/origin/enliven/players/EnlivenPlayer.html?customerId=22&eventId=99315971&checkCompany=1&checkEmail=1&checkName=1
H.C. Wainwright 28th Annual Global Investment Conference (
Presentation Available: Beginning Friday, September 11, 7:00 AM ET
Format: Virtual
Link: https://journey.ct.events/view/eb47953c-3213-432d-92ca-13beb55c97ae
Replays of the investor presentations will be available for 90 days at the links above. During these conferences members of INOVIO's management team will also be conducting one-on-one meetings with investors.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505, investor.relations@inovio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-upcoming-investor-conferences-302866521.html
SOURCE INOVIO Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.